Tamir Biotechnology, Inc. (formerly Alfacell Corporation) targeting microRNAs, is the first company to advance a biopharmaceutical product candidate that works in a manner similar to RNA interference (RNAi) through late-stage clinical trials.
Company Paglalarawan:
the product candidate, onconase®, is an rnase that overcomes the challenges of targeting rna for therapeutic purposes while enabling the development of a new class of therapies for cancer, viral, and other life-threatening diseases.
kopyahin at ilagay ang google mapa na ito sa iyong website o blog!
Pindutin ang pindutan ng kopya at i-paste sa iyong blog o website.
(Mangyaring lumipat sa mode na ' HTML ' kapag nagpo-post sa iyong blog. Examples: WordPress Example, Blogger Example)